Skip to content
AnalystLens

James Hardie Industries 8-K Report (Jan 30, 2026)

Filing Date
Filed January 30, 2026
Period End
January 30, 2026
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

Summary

Summary of the 6-K filed January 30, 2026. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc (ASX / NYSE: JHX) filed this Form 6-K on January 30, 2026, which contains two exhibits and a standard cautionary statement on forward-looking information.

The first exhibit, a January 26, 2026 earnings release, announces that third-quarter fiscal 2026 results will be released after the U.S. market closes on Tuesday, February 10, 2026, and before the Australian market opens on Wednesday, February 11, 2026. Management, CEO Aaron Erter and CFO Ryan Lada, will host a webcast conference call to discuss the results. The second exhibit is an ASX Appendix 3G notice reporting the issuance of 5,821 unquoted JHXAM ordinary shares on January 23, 2026, at a cash issue price of USD 0.69330000 per share.

The filing states these shares were issued in settlement of certain AZEK equity awards outstanding at the closing of the merger, which was consummated on July 1, 2025, under the Agreement and Plan of Merger dated March 23, 2025, as amended. After the issuance, the filing reports 430,436,032 CHESS Depositary Interests quoted on ASX, and unquoted securities of 149,626,141 JHXAM ordinary shares, 5,415,537 restricted stock units, and 269,221 options expiring November 3, 2027 with an exercise price of $33.05a.

Key Highlights

  1. Third-quarter fiscal 2026 results are scheduled for release after the U.S. market close on February 10, 2026, and before the Australian market open on February 11, 2026.
  2. Management will host a webcast conference call with CEO Aaron Erter and CFO Ryan Lada to discuss the results.
  3. An ASX Appendix 3G notice reports the issuance of 5,821 unquoted JHXAM ordinary shares on January 23, 2026.
  4. The shares were issued at a cash price of USD 0.69330000 per share in settlement of certain AZEK equity awards outstanding at the merger closing.
  5. The AZEK merger closed on July 1, 2025, under the Agreement and Plan of Merger dated March 23, 2025, as amended.
  6. Post-issuance, the filing reports 430,436,032 quoted CHESS Depositary Interests and 149,626,141 unquoted JHXAM ordinary shares.
  7. The filing also reports 5,415,537 restricted stock units and 269,221 options expiring November 3, 2027 at an exercise price of $33.05.

Frequently Asked Questions

  1. When will James Hardie report its third-quarter fiscal 2026 results?

    The company will release third-quarter fiscal 2026 results after the U.S. market closes on Tuesday, February 10, 2026, and before the Australian market opens on Wednesday, February 11, 2026.

  2. Who will present the results on the conference call?

    The conference call will be hosted by Aaron Erter, CEO, and Ryan Lada, CFO. It will be webcast live on the company's Investor Relations page.

  3. What share issuance is reported in this filing?

    The filing reports the issuance of 5,821 unquoted JHXAM ordinary shares on January 23, 2026, at a cash issue price of USD 0.69330000 per share. The shares were issued in respect of settlement of certain AZEK equity awards outstanding at the merger closing.

  4. What is the background of the AZEK-related share issuance?

    The filing states that James Hardie consummated its merger with The AZEK Company Inc. on July 1, 2025, under an Agreement and Plan of Merger dated March 23, 2025, as amended. The issued shares settle certain AZEK equity awards outstanding as of the merger closing.

  5. What securities does James Hardie have outstanding after this issuance?

    The filing reports 430,436,032 quoted CHESS Depositary Interests, 149,626,141 unquoted JHXAM ordinary shares, 5,415,537 restricted stock units, and 269,221 options expiring November 3, 2027 with an exercise price of $33.05.